Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Desmorpholinyl Navitoclax-NH-Me (Desmorpholinyl ABT-263-NH-Me) is a Bcl-xL inhibitor, which can be employed alongside a CRBN ligand to synthesize XZ739, a PROTAC BCL-XL degrader [1] [2].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 139.00 | |
5 mg | In stock | $ 347.00 | |
10 mg | In stock | $ 578.00 | |
25 mg | In stock | $ 933.00 | |
50 mg | In stock | $ 1,270.00 | |
100 mg | In stock | $ 1,690.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 586.00 |
Description | Desmorpholinyl Navitoclax-NH-Me (Desmorpholinyl ABT-263-NH-Me) is a Bcl-xL inhibitor, which can be employed alongside a CRBN ligand to synthesize XZ739, a PROTAC BCL-XL degrader [1] [2]. |
Synonyms | Desmorpholinyl ABT-263-NH-Me, Desmorpholinyl Navitoclax-NH-Me |
Molecular Weight | 918.55 |
Formula | C44H51ClF3N5O5S3 |
CAS No. | 2365172-82-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (108.87 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Desmorpholinyl Navitoclax-NH-Me 2365172-82-1 Apoptosis BCL inhibit Target Protein-binding Moiety Bcl-2 Family Desmorpholinyl ABT-263-NH-Me Desmorpholinyl NavitoclaxNHMe Inhibitor Desmorpholinyl Navitoclax NH Me Ligands for Target Protein for PROTAC inhibitor